BERKELEY, Calif. (AP) _ Dynavax Technologies Corp. (DVAX) on Wednesday reported a loss of $42.7 million in its second quarter.
On a per-share basis, the Berkeley, California-based company said it had a loss of 66 cents.
The biopharmaceutical company posted revenue of $8.3 million in the period.
In the final minutes of trading on Wednesday, the company's shares hit $2.99. A year ago, they were trading at $13.70.